Zambon SpA, Emylif 50mg orodispersible film recalled
Class 3 medicines recall: The MHRA has published a Class 3 medicines recall for Emylif 50mg orodispersible film.
Published: 10 November 2025
The Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 3 medicines recall for Emylif 50mg orodispersible film. Zambon SpA is recalling a specific batch as a precautionary measure due to out of specification results for unknown impurities during ongoing stability testing.
Pharmacists are advised to stop supplying the affected batch immediately. Quarantine all stock from this batch and return it to your supplier using your supplier’s approved process.
Further information, advice and details of the affected batch can be found on the MHRA website.